1. Antibody-drug Conjugate/ADC Related Cytoskeleton Cell Cycle/DNA Damage
  2. Antibody-Drug Conjugates (ADCs) Microtubule/Tubulin
  3. Glembatumumab vedotin

Glembatumumab vedotin  (Synonyms: CDX-011; CR011-vcMMAE)

目录号: HY-141604
COA 产品使用指南

Glembatumumab vedotin (CDX-011) 是一种 ADC (Antibody-Drug Conjugates (ADCs)),包含针对糖蛋白 NMB (GPNMB) 的全人 IgG2 单克隆抗体 (CR011),并通过蛋白酶敏感的 vc 接头与强效微管蛋白结合细胞毒剂 MMAE 偶联。Glembatumumab vedotin 具有强大的抗癌作用。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Glembatumumab vedotin Chemical Structure

Glembatumumab vedotin Chemical Structure

CAS No. : 1182215-65-1

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg ¥7400
In-stock
5 mg   询价  
10 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Glembatumumab vedotin (CDX-011) is an ADC (antibody-drug conjugates (ADCs)) comprising a fully human IgG2 monoclonal antibody (CR011) directed against glycoprotein NMB (GPNMB) and conjugated to the potent tubulinbinding cytotoxic agent MMAE via a protease-sensitive vc linker. Glembatumumab vedotin has potent anticancer effects[1].

体外研究
(In Vitro)

Glembatumumab vedotin 与肿瘤上的 GPNMB 结合,复合物被内化,MMAE 通过溶酶体区室中 vc 接头的蛋白水解切割释放。MMAE 抑制微管并导致细胞周期停滞导致肿瘤细胞死亡[1]
Glembatumumab vedotin(1-125 μg/mL;96 小时)表现出骨肉瘤细胞毒活性[3]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[3]

Cell Line: Osteosarcoma cell lines
Concentration: 1 μg/mL to 125 μg/mL
Incubation Time: 96 hours
Result: Demonstrated osteosarcoma cytotoxic activity.
体内研究
(In Vivo)

Glembatumumab vedotin(CR011-vcMMAE;1.25-80 mg/kg;静脉注射;每 4 天一次;持续 16 天)在人类 SK-MEL-2 和 SK-MEL-5 黑色素瘤异种移植模型中显示出短期抗肿瘤作用(抑制肿瘤生长)和长期作用(完全消退)[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Athymic mice (6-week-old) injected with human SK-MEL-2 and SK-MEL-5 melanoma cells[2]
Dosage: 1.25 mg/kg, 2.5 mg/kg, 5 mg/kg, 10 mg/kg, 20 mg/kg, 40 mg/kg, 60 mg/kg, 80 mg/kg
Administration: i.v.; every 4 days; for 16 days
Result: Showed inhibition of tumor growth.
Clinical Trial
CAS 号
性状

液体

颜色

Colorless to light yellow

运输条件

Shipping with dry ice.

储存方式

-80°C, protect from light

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Glembatumumab vedotin
目录号:
HY-141604
需求量: